Results 271 to 280 of about 129,636 (342)

Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
A phase IV, single‐arm, open‐label, multicenter study assessing the safety and efficacy of trastuzumab emtansine in Indian patients for the treatment of human epidermal growth factor receptor 2 (HER2)‐positive unresectable locally advanced or metastatic breast cancer who received prior treatment with trastuzumab and a taxane.
Sudeep Gupta, Manish Singhal, Shona Nag, Waseem Abbas, Dinesh Chandra Doval, Hari Goyal, Chirag Shah, Ashish Singh, Radheshyam Naik, Nitesh Rohatgi, Poonam Patil, Shyam Aggarwal, Vinod Raina, Vaibhav Watts   +13 more
wiley   +1 more source

Creating a Straight Conduit: The Pleural Closure Technique in Ivor Lewis Esophagectomy. [PDF]

Cureus
Loreno EG, Zia M, Chihara R, Naselsky WC, Kim MP.   +4 more
europepmc   +1 more source

Pleura, pleurae, plural - In praise of exactitude.

, 1990
Grant Maxie
openalex   +1 more source

Peri‐operative rehabilitation in patients undergoing elective cardiac valve surgery: a randomised controlled trial

Anaesthesia, EarlyView.
Summary Introduction Patients with valvular heart disease are at high risk of postoperative pulmonary complications, which contribute to morbidity and mortality. However, few studies have focused specifically on peri‐operative rehabilitation in this patient population.
Yuting Liu, Fengyao Liu, Mingyu Xu, Haofeng Zhou, Haochen Wang, Yuanhui Liu, Xuyu He, Huanlei Huang, Tucheng Sun, Xuhua Jian, Jimei Chen, Min Wu, Yijia Sun, Peihua Cao, Jiyan Chen, Lan Guo, Huan Ma   +16 more
wiley   +1 more source

Comparison of low- and standard-dose CT-guided transthoracic core needle biopsies: Feasibility, safety, diagnostic yield, and radiation dose. [PDF]

Acta Radiol Open
Aytaç A, Gürel K, Yılmazsoy Y, Hızal M, Düzcü SE, Kalaycıoğlu O.   +5 more
europepmc   +1 more source

Single‐dose Pasteurella multocida and Histophilus somni autogenous vaccines administered at induction significantly improved feedlot cattle performance and profitability in Australia

Australian Veterinary Journal, EarlyView.
Background Bovine respiratory disease (BRD) is the most economically important disease affecting feedlot cattle. While viral pathogens are initiating agents, bacterial coinfections exacerbate disease severity. Vaccines for Pasteurella multocida and Histophilus somni are not commercially available in Australia.
GM Werid, T Batterham, L O'Meara, K Petrovski, WS Pitchford, DJ Trott   +5 more
wiley   +1 more source

Late-onset esophagogastric anastomotic fistula managed without continuous fasting: a case report. [PDF]

J Surg Case Rep
Gong Y, Zhang Y, Ma H, Jiang W, Liu J, Kang Y, Liu J, Yu X.   +7 more
europepmc   +1 more source

AOSNP‐ADAPTR resource level‐based recommendations on practical diagnostic strategies for WHO CNS5 adult‐type diffuse gliomas

Brain Pathology, EarlyView.
ADAPTR recommendations for Adult‐type Diffuse Gliomas in Resource‐restrained settings. Abstract The fifth edition of the WHO classification of CNS Tumors (WHO CNS5) has revised the diagnostic and grading criteria for Adult‐type Diffuse Gliomas (ADGs) by integrating molecular parameters with histologic features.
Vani Santosh, Chitra Sarkar, Shilpa Rao, Ho‐Keung Ng, Junji Shibahara, Maysa Al‐Hussaini, Michael E. Buckland, Sung‐Hye Park, Tarik Tihan, Pieter Wesseling, David N. Louis, Takashi Komori   +11 more
wiley   +1 more source

Case Report: IL-6 suppression: a potential strategy for mitigating severe immune-related adverse events in nivolumab and ipilimumab therapy for malignant pleural mesothelioma. [PDF]

Front Oncol
Yanagisawa A, Fukaya T, Noda K, Kojima H, Shimizu H.   +4 more
europepmc   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source